CLN2 Disease
Neurology
Prevalence
0.1 / 100K
1 drug in development·1 company·0 clinical trials
Drug Pipeline by Phase
Preclinical(1)
| Drug | Company |
|---|---|
| spk-tpp1 | Spark Therapeutics, Inc. (SPARK) |
Frequently asked questions
How many drugs are in development for CLN2 Disease?
BioSniper tracks 1 drug in development for CLN2 Disease across 1 company.
What is the prevalence of CLN2 Disease?
The estimated prevalence of CLN2 Disease is approximately 0.1 per 100,000 population.
Deep-dive into CLN2 Disease
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis